Recent Courses

Clinical Strategies & Scientific Advances in HEPATITIS C VIRUS (HCV)
  • 1.25 AMA PRA Category 1 Credit(s)™ credits
  • 1.25 Non-physician credits
The treatment of HCV has undergone a dramatic evolution in the last several years. Whereas traditional interferon-based therapy for HCV was limited by poor efficacy and a heavy burden of side effects, interferon-free antiviral regimens are now available, offering new options for patients and altering the approach to this serious disease. The rapid...
AHA 2016: Advances in the Management of Patients with Heart Failure
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This discussion-based, CME program will feature imperative information for the treatment and management of patients with heart failure presented at the American Heart Association Scientific Sessions 2016 held in Orlando, Florida. Predictors of heart failure, patient assessment techniques and risk-benefit considerations for patients, both in the...
New Considerations for the Treatment of Glioblastoma Multiforme: Evaluating the...
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
The content for this activity is based on the satellite symposium, “New Considerations for the Treatment of Glioblastoma Multiforme: Evaluating the Potential for Immune Checkpoint Inhibitors”, that was presented at the 21st Annual Meeting of the Society for Neuro-Oncology in Scottsdale, Arizona on November 17, 2016. Glioblastoma multiforme (GBM)...
AHA 2016: Update on Lipid Lowering Therapies
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will focus on new and emerging therapeutic options in the management of patients with dyslipidemia that were discussed at the American Heart Association Annual Congress 2016 in New Orleans, Louisiana.  The expert faculty will evaluate clinical trial data and the responsiveness to therapeutic agents. They will discuss the science...
Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve...
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
  • 2.00 Nursing Contact Hours credits
The content for this activity is based on the satellite symposium, “Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis”, that was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida on October 28, 2016. The content highlights the latest...
Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis...
  • 1.25 AMA PRA Category 1 Credit(s)™ credits
  • 1.25 Non-physician credits
The content for this activity is based on the satellite symposium Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment that was presented on October 24, 2016 in Los Angeles, CA. Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive...
An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease...
  • 0.75 AMA PRA Category 1 Credit(s)™ credits
  • 0.75 Non-physician credits
The 9th annual meeting of Clinical Trials on Alzheimer’s Disease (CTAD) was held in San Diego, California, December 8-10, 2016. CTAD has become one of the most important scientific meetings in the Alzheimer’s disease (AD) area. It brings together today’s global leaders in AD to discuss new results, candidate therapeutics, and methodological issues...
ESC 2016: Applying Novel Therapeutics to Improve Outcomes in Patients with...
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
This CME program will cover data on current and emerging therapeutic options for treating patients with pulmonary arterial hypertension (PAH) that was presented at the European Society of Cardiology 2016 Annual Congress held in Rome, Italy. The expert faculty will discuss recent clinical trial data on pulmonary arterial hypertension along with...
Long-Acting Reversible Contraception: An Important Solution to Reduce...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
The content for this activity is based on the satellite symposium Long-Acting Reversible Contraception: An Important Solution to Reduce Unintended Pregnancy that was presented at The American Congress of Obstetricians and Gynecologists (ACOG) Annual District II Meeting in New York, New York, on October 22, 2016.  Despite the availability of...
ECTRIMS 2016: Utilizing Individualized Treatment Plans to Optimally Manage...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will focus on the new and emerging therapeutic options for the management of patients with multiple sclerosis (MS) that were discussed at the 2016 ECTRIMS Annual Meeting in London, United Kingdom from September 14 – 17, 2016. This activity will educate healthcare providers about novel techniques and optimal management strategies...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.